Atlas Trials

Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers

Clinical trial NCT06435221 · COMPLETED

Trial details

NCT number
NCT06435221
Sponsor
Achieve Life Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Smoking CessationVaping Cessation
Start date
2024-05-28
Primary completion
2025-09-29
Enrollment
479

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.